Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Say goodbye to muted tones. Popular DIY and home TikTok creator Tina Le Mac (@tinalemac) believes that muted neutral colors will stay behind in favor of brighter and bolder hues.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Testing is the biggest expenditure in his tirzepatide-making process (he and other DIY-ers send their samples for testing in bulk for extra assurance and cost savings).

Tirzepatide may be more effective than semaglutide in helping people who have obesity or overweight lose weight, results from a recent study suggest.

Shady drugmaker used code words to sell knockoff weight-loss drug: Lawsuit After cease-and-desist letter, Pivotal Peptides allegedly sold mix-your-own tirzepatide as "11 mg." ...

Among incident users, observed trends were similar. Compared with initial postapproval periods for other medications, tirzepatide uptake was more rapid and sustained.

Key takeaways: Adults with overweight or obesity using tirzepatide lost more weight than those using semaglutide. Moderate to severe gastrointestinal events were similar between the two medications.

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake trends in commercial claims data.

Eli Lilly and Company is conducting a clinical study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...

Ostrominski JW, Ortega-Montiel J, Tesfaye H, et al. Trends in utilization of glucose- and weight-lowering medications after tirzepatide approval in the United States: a population-based cohort study.